Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Orientin reduces the inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on adipogenic differentiation and insulin signaling pathway in murine 3T3-L1 adipocytes.

Choi EM, Suh KS, Park SY, Yun S, Chin SO, Rhee SY, Chon S.

Chem Biol Interact. 2020 Feb 7;318:108978. doi: 10.1016/j.cbi.2020.108978. [Epub ahead of print]

PMID:
32044341
2.

A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus.

Lee MK, Kim SG, Watkins E, Moon MK, Rhee SY, Frias JP, Chung CH, Lee SH, Block B, Cha BS, Park HK, Kim BJ, Greenway F.

J Diabetes Complications. 2020 Feb 2:107555. doi: 10.1016/j.jdiacomp.2020.107555. [Epub ahead of print]

PMID:
32019723
3.

Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.

Tzou PL, Descamps D, Rhee SY, Raugi DN, Charpentier C, Taveira N, Smith RA, Soriano V, de Mendoza C, Holmes SP, Gottlieb GS, Shafer RW.

J Infect Dis. 2020 Jan 22. pii: jiaa026. doi: 10.1093/infdis/jiaa026. [Epub ahead of print]

PMID:
31965175
4.

Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease.

Hippen KL, Aguilar EG, Rhee SY, Bolivar-Wagers S, Blazar BR.

Trends Immunol. 2020 Jan;41(1):77-91. doi: 10.1016/j.it.2019.11.005. Epub 2019 Nov 30. Review.

PMID:
31791718
5.

Body mass index, diabetes, and the risk of Parkinson's disease.

Jeong SM, Han K, Kim D, Rhee SY, Jang W, Shin DW.

Mov Disord. 2020 Feb;35(2):236-244. doi: 10.1002/mds.27922. Epub 2019 Nov 30.

PMID:
31785021
6.

HIV-1 viral load is elevated in individuals with reverse transcriptase mutation M184V/I during virological failure of first line antiretroviral therapy and is associated with compensatory mutation L74I.

Gregson J, Rhee SY, Datir R, Pillay D, Perno CF, Derache A, Shafer RS, Gupta RK.

J Infect Dis. 2019 Nov 27. pii: jiz631. doi: 10.1093/infdis/jiz631. [Epub ahead of print]

PMID:
31774913
7.

Systems genomics approaches provide new insights into Arabidopsis thaliana root growth regulation under combinatorial mineral nutrient limitation.

Bouain N, Korte A, Satbhai SB, Nam HI, Rhee SY, Busch W, Rouached H.

PLoS Genet. 2019 Nov 6;15(11):e1008392. doi: 10.1371/journal.pgen.1008392. eCollection 2019 Nov.

8.

Tetrabromobisphenol A Promotes the Osteoclastogenesis of RAW264.7 Cells Induced by Receptor Activator of NF-kappa B Ligand In Vitro.

Park SY, Choi EM, Suh KS, Kim HS, Chin SO, Rhee SY, Kim DY, Oh S, Chon S.

J Korean Med Sci. 2019 Oct 28;34(41):e267. doi: 10.3346/jkms.2019.34.e267.

9.

Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.

Tzou PL, Rhee SY, Descamps D, Clutter DS, Hare B, Mor O, Grude M, Parkin N, Jordan MR, Bertagnolio S, Schapiro JM, Harrigan PR, Geretti AM, Marcelin AG, Shafer RW; WHO HIVResNet Working Groups.

J Antimicrob Chemother. 2020 Jan 1;75(1):170-182. doi: 10.1093/jac/dkz417.

PMID:
31617907
10.

Incidence of Diabetes Mellitus in Male Moderate Alcohol Drinkers: A Community-Based Prospective Cohort Study.

Park SY, Jeong SJ, Ustulin M, Chon S, Woo JT, Lim JE, Oh B, Rhee SY.

Arch Med Res. 2019 Jul;50(5):315-323. doi: 10.1016/j.arcmed.2019.08.008. Epub 2019 Oct 7.

PMID:
31600603
11.

Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.

Lee YH, Kim KP, Park SH, Kim DJ, Kim YG, Moon JY, Jung SW, Kim JS, Jeong KH, Lee SY, Yang DH, Lim SJ, Woo JT, Rhee SY, Chon S, Choi HY, Park HC, Jo YI, Yi JH, Han SW, Lee SH.

Nephrol Dial Transplant. 2019 Oct 10. pii: gfz168. doi: 10.1093/ndt/gfz168. [Epub ahead of print]

PMID:
31598726
12.

Effect of Dipeptidyl Peptidase-4 Inhibitors on the Risk of Bone Fractures in a Korean Population.

Ustulin M, Park SY, Choi H, Chon S, Woo JT, Rhee SY.

J Korean Med Sci. 2019 Sep 9;34(35):e224. doi: 10.3346/jkms.2019.34.e224.

13.

2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.

Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, Kim NH, Kim SY, Rhee SY, Lee KW, Kim JH, Rhee EJ, Chun S, Yu SH, Kim DJ, Kwon HS, Park KS; Committee of Clinical Practice Guidelines, Korean Diabetes Association.

Diabetes Metab J. 2019 Aug;43(4):398-406. doi: 10.4093/dmj.2019.0137. Review.

14.

Catalpol protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytotoxicity in osteoblastic MC3T3-E1 cells.

Choi EM, Suh KS, Jung WW, Yun S, Park SY, Chin SO, Rhee SY, Chon S.

J Appl Toxicol. 2019 Dec;39(12):1710-1719. doi: 10.1002/jat.3896. Epub 2019 Aug 19.

PMID:
31429101
15.

QTG-Finder: A Machine-Learning Based Algorithm To Prioritize Causal Genes of Quantitative Trait Loci in Arabidopsis and Rice.

Lin F, Fan J, Rhee SY.

G3 (Bethesda). 2019 Oct 7;9(10):3129-3138. doi: 10.1534/g3.119.400319.

16.

Amino Acid Prevalence of HIV-1 pol Mutations by Direct Polymerase Chain Reaction and Single Genome Sequencing.

Tzou PL, Rhee SY, Shafer RW.

AIDS Res Hum Retroviruses. 2019 Oct;35(10):924-929. doi: 10.1089/AID.2018.0289. Epub 2019 Aug 26.

PMID:
31317771
17.

A systematic review of the genetic mechanisms of dolutegravir resistance.

Rhee SY, Grant PM, Tzou PL, Barrow G, Harrigan PR, Ioannidis JPA, Shafer RW.

J Antimicrob Chemother. 2019 Nov 1;74(11):3135-3149. doi: 10.1093/jac/dkz256.

18.

Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis.

Chimukangara B, Lessells RJ, Rhee SY, Giandhari J, Kharsany ABM, Naidoo K, Lewis L, Cawood C, Khanyile D, Ayalew KA, Diallo K, Samuel R, Hunt G, Vandormael A, Stray-Pedersen B, Gordon M, Makadzange T, Kiepiela P, Ramjee G, Ledwaba J, Kalimashe M, Morris L, Parikh UM, Mellors JW, Shafer RW, Katzenstein D, Moodley P, Gupta RK, Pillay D, Abdool Karim SS, de Oliveira T.

EClinicalMedicine. 2019 Mar 18;9:26-34. doi: 10.1016/j.eclinm.2019.03.006. eCollection 2019 Mar.

19.

National and International Dimensions of Human Immunodeficiency Virus-1 Sequence Clusters in a Northern California Clinical Cohort.

Rhee SY, Magalis BR, Hurley L, Silverberg MJ, Marcus JL, Slome S, Kosakovsky Pond SL, Shafer RW.

Open Forum Infect Dis. 2019 Mar 14;6(4):ofz135. doi: 10.1093/ofid/ofz135. eCollection 2019 Apr.

20.

Biochanin A prevents 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced adipocyte dysfunction in cultured 3T3-L1 cells.

Choi EM, Suh KS, Park SY, Chin SO, Rhee SY, Chon S.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2019;54(9):865-873. doi: 10.1080/10934529.2019.1603746. Epub 2019 Apr 20.

PMID:
31007129
21.

Genome-wide association study identifies new susceptibility loci for diabetic nephropathy in Korean patients with type 2 diabetes mellitus.

Jeong KH, Kim JS, Woo JT, Rhee SY, Lee YH, Kim YG, Moon JY, Kim SK, Kang SW, Lee SH, Kim YH; Representing KNOW-CKD Study Group and KNDP Study Group.

Clin Genet. 2019 Jul;96(1):35-42. doi: 10.1111/cge.13538. Epub 2019 Apr 9.

PMID:
30883692
22.

Towards Building a Plant Cell Atlas.

Rhee SY, Birnbaum KD, Ehrhardt DW.

Trends Plant Sci. 2019 Apr;24(4):303-310. doi: 10.1016/j.tplants.2019.01.006. Epub 2019 Feb 16. Review.

PMID:
30777643
23.

Gene-environment interactions related to blood pressure traits in two community-based Korean cohorts.

Lim JE, Kim HO, Rhee SY, Kim MK, Kim YJ, Oh B.

Genet Epidemiol. 2019 Jun;43(4):402-413. doi: 10.1002/gepi.22195. Epub 2019 Feb 15.

PMID:
30770579
24.

METACLUSTER-an R package for context-specific expression analysis of metabolic gene clusters.

Banf M, Zhao K, Rhee SY.

Bioinformatics. 2019 Sep 1;35(17):3178-3180. doi: 10.1093/bioinformatics/btz021.

PMID:
30657869
25.

Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa.

Chimukangara B, Kharsany ABM, Lessells RJ, Naidoo K, Rhee SY, Manasa J, Gräf T, Lewis L, Cawood C, Khanyile D, Diallo K, Ayalew KA, Shafer RW, Hunt G, Pillay D, Abdool SK, de Oliveira T.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):129-138. doi: 10.1089/AID.2018.0202. Epub 2019 Jan 7.

26.

Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study.

Rhee SY, Chon S, Ahn KJ, Woo JT; Korean Diabetes Prevention Study Investigators.

Diabetes Metab J. 2019 Feb;43(1):49-58. doi: 10.4093/dmj.2018.0033. Epub 2018 Nov 2.

27.

Importance of family history of diabetes in computing a diabetes risk score in Korean prediabetic population.

Ustulin M, Rhee SY, Chon S, Ahn KK, Lim JE, Oh B, Kim SH, Baik SH, Park Y, Nam MS, Lee KW, Kim YS, Woo JT.

Sci Rep. 2018 Oct 29;8(1):15958. doi: 10.1038/s41598-018-34411-w.

28.

Radial Nerve Injury Caused by Compression Garment for Lymphedema: A Case Report.

Rhee SY, Lee SY, Jeon HR.

PM R. 2019 Apr;11(4):436-439. doi: 10.1016/j.pmrj.2018.09.039. Epub 2019 Feb 22.

PMID:
30300765
29.

Compound Heterozygous Pathogenic Variants of the 15-Hydroxyprostaglandin Dehydrogenase Gene in a Patient With Hypertrophic Osteoarthropathy: First Case in Korea.

Ryu MR, Yang JH, Rhee SY, Cho A, Kim SY, Ki CS.

Ann Lab Med. 2019 Jan;39(1):105-108. doi: 10.3343/alm.2019.39.1.105. No abstract available.

30.

Cardio-Ankle Vascular Index as a Surrogate Marker of Early Atherosclerotic Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus.

Park SY, Chin SO, Rhee SY, Oh S, Woo JT, Kim SW, Chon S.

Diabetes Metab J. 2018 Aug;42(4):285-295. doi: 10.4093/dmj.2017.0080. Epub 2018 Jul 27.

31.

The Role of Advanced Glycation End Products in Diabetic Vascular Complications.

Rhee SY, Kim YS.

Diabetes Metab J. 2018 May 31. [Epub ahead of print]

PMID:
30112876
32.

Geographically-stratified HIV-1 group M pol subtype and circulating recombinant form sequences.

Rhee SY, Shafer RW.

Sci Data. 2018 Jul 31;5:180148. doi: 10.1038/sdata.2018.148.

33.

Glabridin attenuates antiadipogenic activity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine 3T3-L1 adipocytes.

Choi EM, Suh KS, Jung WW, Park SY, Chin SO, Rhee SY, Kim Pak Y, Chon S.

J Appl Toxicol. 2018 Nov;38(11):1426-1436. doi: 10.1002/jat.3664. Epub 2018 Jul 26.

PMID:
30051472
34.

Selection analyses of paired HIV-1 gag and gp41 sequences obtained before and after antiretroviral therapy.

Tzou PL, Rhee SY, Pond SLK, Manasa J, Shafer RW.

Sci Data. 2018 Jul 24;5:180147. doi: 10.1038/sdata.2018.147.

35.

Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy.

Rhee SY, Jung ES, Park HM, Jeong SJ, Kim K, Chon S, Yu SY, Woo JT, Lee CH.

Metabolomics. 2018;14(7):89. doi: 10.1007/s11306-018-1383-3. Epub 2018 Jun 21.

36.

Air Pollution Has a Significant Negative Impact on Intentional Efforts to Lose Weight: A Global Scale Analysis.

Ustulin M, Park SY, Chin SO, Chon S, Woo JT, Rhee SY.

Diabetes Metab J. 2018 Aug;42(4):320-329. doi: 10.4093/dmj.2017.0104. Epub 2018 Apr 24.

37.

The Role of Advanced Glycation End Products in Diabetic Vascular Complications.

Rhee SY, Kim YS.

Diabetes Metab J. 2018 Jun;42(3):188-195. doi: 10.4093/dmj.2017.0105. Epub 2018 May 31. Review.

38.

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.

Rhee SY, Clutter D, Fessel WJ, Klein D, Slome S, Pinsky BA, Marcus JL, Hurley L, Silverberg MJ, Kosakovsky Pond SL, Shafer RW.

Clin Infect Dis. 2019 Jan 7;68(2):213-221. doi: 10.1093/cid/ciy453.

39.

Xanthohumol ameliorates 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cellular toxicity in cultured MC3T3-E1 osteoblastic cells.

Suh KS, Choi EM, Kim HS, Park SY, Chin SO, Rhee SY, Pak YK, Choe W, Ha J, Chon S.

J Appl Toxicol. 2018 Jul;38(7):1036-1046. doi: 10.1002/jat.3613. Epub 2018 Mar 8.

PMID:
29516522
40.

27-Deoxyactein prevents 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cellular damage in MC3T3-E1 osteoblastic cells.

Suh KS, Choi EM, Jung WW, Park SY, Chin SO, Rhee SY, Pak YK, Chon S.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2018 May 12;53(6):561-570. doi: 10.1080/10934529.2018.1428275. Epub 2018 Jan 24.

PMID:
29364047
41.
42.

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association.

Kim HJ, Park SO, Ko SH, Rhee SY, Hur KY, Kim NH, Moon MK, Lee BW, Kim JH, Choi KM; Committee of Clinical Practice Guidelines of the Korean Diabetes Association.

Diabetes Metab J. 2017 Dec;41(6):423-429. doi: 10.4093/dmj.2017.41.6.423. Review.

43.

Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial.

Chon S, Rhee SY, Ahn KJ, Baik SH, Park Y, Nam MS, Lee KW, Yoo SJ, Koh G, Lee DH, Kim YS, Woo JT; KIIT study investigators.

Diabetes Obes Metab. 2018 May;20(5):1121-1130. doi: 10.1111/dom.13196. Epub 2018 Jan 22.

PMID:
29272062
44.

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus.

Moon MK, Hur KY, Ko SH, Park SO, Lee BW, Kim JH, Rhee SY, Kim HJ, Choi KM, Kim NH; Committee of Clinical Practice Guidelines of the Korean Diabetes Association.

Korean J Intern Med. 2017 Nov;32(6):974-983. doi: 10.3904/kjim.2017.354. Epub 2017 Oct 27. Review.

45.

Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data.

Park S, Rhee SY, Jeong SJ, Kim K, Chon S, Yu SY, Woo JT.

Diabetes Metab J. 2017 Oct;41(5):393-404. doi: 10.4093/dmj.2017.41.5.393.

46.

Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017.

Lee BW, Kim JH, Ko SH, Hur KY, Kim NH, Rhee SY, Kim HJ, Moon MK, Park SO, Choi KM; Committee of Clinical Practice Guideline of Korean Diabetes Association.

Diabetes Metab J. 2017 Oct;41(5):367-373. doi: 10.4093/dmj.2017.41.5.367. Review.

47.

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus.

Moon MK, Hur KY, Ko SH, Park SO, Lee BW, Kim JH, Rhee SY, Kim HJ, Choi KM, Kim NH; Committee of Clinical Practice Guidelines of the Korean Diabetes Association.

Diabetes Metab J. 2017 Oct;41(5):357-366. doi: 10.4093/dmj.2017.41.5.357. Review.

48.

Monotherapy in Patients with Type 2 Diabetes Mellitus.

Rhee SY, Kim HJ, Ko SH, Hur KY, Kim NH, Moon MK, Park SO, Lee BW, Choi KM, Kim JH; Committee of Clinical Practice Guideline of Korean Diabetes Association.

Diabetes Metab J. 2017 Oct;41(5):349-356. doi: 10.4093/dmj.2017.41.5.349. Review.

49.

Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association.

Ko SH, Hur KY, Rhee SY, Kim NH, Moon MK, Park SO, Lee BW, Kim HJ, Choi KM, Kim JH; Committee of Clinical Practice Guideline of Korean Diabetes Association.

Diabetes Metab J. 2017 Oct;41(5):337-348. doi: 10.4093/dmj.2017.41.5.337. Review.

50.

Monotherapy in patients with type 2 diabetes mellitus.

Rhee SY, Kim HJ, Ko SH, Hur KY, Kim NH, Moon MK, Park SO, Lee BW, Choi KM, Kim JH; Committee of Clinical Practice Guideline of Korean Diabetes Association.

Korean J Intern Med. 2017 Nov;32(6):959-966. doi: 10.3904/kjim.2017.312. Epub 2017 Oct 23. Review.

Supplemental Content

Support Center